Inorganic nanomaterials activate the cGAS-STING pathway for tumor treatment

Pharmacology and Therapeutics · Published 2026-07-24 · DOI 10.1016/j.pharmthera.2026.109088

Authors (4)

Youdong Chen, Qian Li, Jinhua Zhou, Liang Cheng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chen, Y., Li, Q., Zhou, J., et al. (2026). Inorganic nanomaterials activate the cGAS-STING pathway for tumor treatment. Pharmacology and Therapeutics. https://doi.org/10.1016/j.pharmthera.2026.109088

Related articles

• Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy · Journal of Experimental & Clinical Cancer Research · 2026 · Cites or is cited by this article
• The aftermath of alcohol misuse: Linking cellular damage, suboptimal micronutrient nutrition, and organ dysfunction · Pharmacology and Therapeutics · 2026 · Same journal
• A dive into the untapped potential of marine compounds in counteracting neurodegeneration · Pharmacology and Therapeutics · 2026 · Same journal
• Mathematical modeling of T cell exhaustion in the tumor microenvironment · Pharmacology and Therapeutics · 2026 · Same journal
• C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy · Pharmacology and Therapeutics · 2026 · Same journal
• Circular RNA serves as an upstream regulator of the miRNA//ABCC1 axis in human cancers · Pharmacology and Therapeutics · 2026 · Same journal
• Clinical relevance of per-particle atherogenicity of triglyceride-rich lipoproteins, Lp(a) and LDL for cardiovascular risk · Pharmacology and Therapeutics · 2026 · Same journal
• Therapeutic potential of targeting novel signaling pathways in regulating chronic inflammation in obstructive lung disorders · Pharmacology and Therapeutics · 2026 · Same journal
• Incretin-based therapies: Effects on plasma lipids and potential mechanisms · Pharmacology and Therapeutics · 2026 · Same journal
• Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistance · Pharmacology and Therapeutics · 2026 · Same journal